Group 1 - The Hong Kong Innovative Drug 50 ETF (513780) increased by 0.06% on December 10, with a trading volume of 238 million yuan [1] - The fund's shares increased by 23.5 million, bringing the total shares to 1.802 billion, although there was a decrease of 54 million shares over the last 20 trading days [1] - The latest net asset value of the fund is 2.995 billion yuan [1] Group 2 - The performance benchmark for the Hong Kong Innovative Drug 50 ETF is the CSI Hong Kong Stock Connect Innovative Drug Index return rate, adjusted for valuation exchange rates [1] - The fund is managed by Invesco Great Wall Fund Management Co., with Jin Huang as the fund manager [1] - Since its establishment on October 16, 2024, the fund has achieved a return of 66.26%, while the return over the past month is -2.52% [1]
12月10日港股创新药50ETF（513780）份额增加2350.00万份
Xin Lang Cai Jing·2025-12-11 01:13